- Financial Times•yesterday
Big pharma thinks it has spotted its next big opportunity - an untreatable silent killer that affects millions of people. In recent months, large drugmakers including Allergan, Gilead and Novartis have ...
- Motley Fool•2 days ago
These drug kingpins are raking in the dough, which could lead to handsome returns for investors.
- Zacks•5 days ago
Shire's (SHPG) fourth-quarter results were encouraging with the company beating both top- and bottom-line estimates.
SHP.L : Summary for SHIRE PLC ORD 5P - Yahoo Finance
Shire plc (SHP.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||4,812.50 x 51000|
|Ask||4,815.00 x 53800|
|Day's Range||4,786.00 - 4,826.00|
|52 Week Range||2,707.19 - 5,377.00|
|PE Ratio (TTM)||220.80|
|Dividend & Yield||0.26 (0.44%)|
|1y Target Est||N/A|